Health economic evaluation using Markov models in R for Microsoft excel users: a tutorial

N Green, F Lamrock, N Naylor, J Williams, A Briggs - PharmacoEconomics, 2023 - Springer
A health economic evaluation (HEE) is a comparative analysis of alternative courses of
action in terms of both costs and consequences. A cost-effectiveness analysis is a type of …

Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease

CN Kohli-Lynch, J Lewsey, KA Boyd, DD French… - Circulation, 2022 - Am Heart Assoc
Background: Cholesterol guidelines typically prioritize primary prevention statin therapy on
the basis of 10-year risk of cardiovascular disease. The advent of generic pricing may justify …

assertHE: an R package to improve quality assurance of HTA models

RA Smith, Y Samyshkin… - Wellcome Open …, 2024 - wellcomeopenresearch.org
Background Health economic models are increasingly used to inform decisions about the
allocation of healthcare resources. Ensuring the robustness and reliability of these models is …

Review of open libraries for pharmacoeconomic analysis in R environment

IA Lackman, RI Sladkov… - …, 2024 - pharmacoeconomics.ru
Background. To reveal the full complexity of the relationship between medical intervention
and disease outcome, new methods of analysis and modeling are actively being developed …

Improving the validity and usability of decision models: case studies with a focus on physical activity

R Smith - 2023 - etheses.whiterose.ac.uk
Background: Health economic evaluation has a crucial role to play in the allocation of scarce
societal resources. Economic models used in these evaluations must have a high degree of …

Exploring the role of replication in health economic decision models

E Mcmanus - 2023 - ueaeprints.uea.ac.uk
Several scientific disciplines have announced a “reproducibility crisis”, initiated by numerous
high-profile studies being found to be unreproducible. Although health economic research …

[引用][C] Обзор открытых библиотек фармакоэкономического анализа в среде R

ИА Лакман, РИ Сладков… - ФАРМАКОЭКОНОМИКА …, 2024 - IRBIS LLC